Paratek Pharmaceuticals
PRTK
#9025
Rank
A$0.17 B
Marketcap
A$3.13
Share price
0.00%
Change (1 day)
2.40%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -A$66.28 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are A$0.16 Billion. In 2022 the company made an earning of -A$63.75 Million a decrease over its 2021 earnings that were of -A$57.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$66.28 Million3.98%
2022 -A$63.75 Million10.5%
2021 -A$57.69 Million-46.16%
2020 -A$0.11 Billion-31.93%
2019 -A$0.16 Billion11.12%
2018 -A$0.15 Billion21.19%
2017 -A$0.12 Billion-23.22%
2016 -A$0.16 Billion54.68%
2015 -A$98.43 Million309.5%
2014 -A$24.04 Million-29.88%
2013 -A$34.28 Million
2011 -A$5.29 Million-59.18%
2010 -A$12.96 Million-53.53%
2009 -A$27.88 Million-161.93%
2008 A$45 M-187.43%
2007 -A$51.47 Million11.93%
2006 -A$45.99 Million31.69%
2005 -A$34.92 Million32.4%
2004 -A$26.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-A$0.73 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$86.9 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$29.01 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA